MedTrace Logo

Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer

NCT01403103 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2014-01-17

No results posted yet for this study

Summary

This pilot clinical trial studies cholecalciferol in treating patients with colorectal cancer. The use of cholecalciferol may slow disease progression in patients with colorectal cancer.

Conditions

  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Signet Ring Adenocarcinoma of the Colon
  • Signet Ring Adenocarcinoma of the Rectum
  • Stage I Colon Cancer
  • Stage I Rectal Cancer

Interventions

DIETARY_SUPPLEMENT

cholecalciferol

Given PO

PROCEDURE

biopsy

Correlative studies

GENETIC

protein expression analysis

Correlative studies

OTHER

enzyme-linked immunosorbent assay

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

GENETIC

reverse transcriptase-polymerase chain reaction

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Smitha Krishnamurthi, MD · Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

  • Matthew Kalady, MD · Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-01-31
Completion
2014-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01403103 on ClinicalTrials.gov